Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium
In This Article:
Hematology Oncology of Indiana’s M. Sarfraz Nawaz, MD, investigated improvement in approaches to febrile neutropenia in cancer patients
Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium
INDIANAPOLIS, IN, July 11, 2024 (GLOBE NEWSWIRE) -- Local medical oncologist M. Sarfraz Nawaz, MD, co-authored a quality improvement research project on febrile neutropenia that was accepted and presented at the 21st International Ultmann Chicago Lymphoma Symposium in Chicago, which was held April 19 through April 20.
The research project “Neutropenic Patient Care at Ascension St. Vincent Hospital - Indianapolis" investigated improving the care of patients with febrile neutropenia. This dangerous complication in cancer patients increases their risk of serious infections, leading to higher mortality rates among this segment and an increased strain on healthcare resources.
This research project aims to create a standard precaution protocol for hospitalized neutropenic patients, improve education and investigate its effectiveness in improving patient outcomes through new interventions. Over the next six months, the ongoing study will collect data on inpatient admissions with neutropenia billing codes to inform the development of this standardized protocol, ultimately leading to better care for these vulnerable patients.
“It was an esteemed honor to share our research and findings with the distinguished audience who attended the symposium,” said Dr. Nawaz. “The selection process was rigorous, and having our study chosen significantly validated the project’s value to the field. Sharing the stage with my colleagues and presenting our findings at the symposium was a significant learning experience. It fostered a sense of personal growth and reinforced the importance of contributing to advancing knowledge in lymphoma treatment.”
The International Ultmann Chicago Lymphoma Symposium is an industry-leading annual conference focused on the science and clinical care of lymphoma. Attendees include medical oncologists, advanced nurse practitioners, physician assistants, nurses, residents, fellows and the Chicago academic community.
“Congratulations to Dr. Nawaz on having the opportunity to share this vital research at the symposium,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Seeing our physicians contributing to advancing medical knowledge is always exciting. Here at AON, we foster a culture of research and scholarly exchange — both of which serve as core values. Encouraging participation in studies and sharing the findings allow us to improve patient care at our own practices and influence the collective understanding of healthcare and cancer care on a wider scale.”